Legal expert in health care, partner, and cochair of the health care coverage and reimbursement practice at Foley Hoag LLP, Ross Margulies discusses his excitement and expectations as a featured speaker at the upcoming 2024 AMCP Annual Conference.
The Academy of Managed Care Pharmacy (AMCP) is hosting its annual conference in New Orleans this year from April 15-18, and will be attracting over 4000 attendees.
One of the featured speakers is Ross Margulies, a health care attorney and partner at Foley Hoag LLP. Margulies will be focusing on health care reform and its impact on pharmacy benefit managers (PBMs). In this interview, he shares his expectations for the conference and the key takeaways he hopes attendees will gain.
Transcript
What are you looking forward to most at AMCP?
I've been to AMCP conferences many times over the last 6 or 7 years probably. Frankly, what I love about AMCP is it's one of the few forums where you get together different stakeholders, pharmacies, managed care pharmacies, community pharmacies, PBMs, manufacturers, and you talk about some of the tough issues. I'm talking about one of them, which is PBM reform. You know, it's pretty rare these days that you get diverse perspectives, and I honestly think a lot of really interesting conversations happen because of that.
What are you hoping attendees can take away from the meeting this year?
With respect to PBM reforms, I'd like my attendees to know what Congress is considering because it's filled with a lot of jargon, it’s very confusing. But I think the chance that there is going to be some type of PBM reform is pretty likely. No matter where you are on the drug supply chain, understanding what those provisions are and how they impact you is going to be really necessary, so that's my goal.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More